​
​

Teva Pharmaceutical Industries (TEVA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Teva Pharmaceutical Industries Revenue Highlights

Latest Revenue (Y)

$15.85B

Latest Revenue (Q)

$4.33B

Main Segment (Y)

International Markets

Main Geography (Y)

North America

Teva Pharmaceutical Industries Revenue by Period

Teva Pharmaceutical Industries Revenue by Year

DateRevenueChange
2023-12-31-6.17%
2022-12-31--6.00%
2021-12-31--4.68%
2020-12-31--1.36%
2019-12-31--10.43%
2018-12-31--15.77%
2017-12-31-2.20%
2016-12-31-11.45%
2015-12-31--3.06%
2014-12-31--0.21%
2013-12-31--0.01%
2012-12-31-10.95%
2011-12-31-13.59%
2010-12-31-15.99%
2009-12-31-25.39%
2008-12-31-17.83%
2007-12-31-11.89%
2006-12-31-60.14%
2005-12-31-9.41%
2004-12-31-46.47%
2003-12-31-30.09%
2002-12-31-21.24%
2001-12-31-18.72%
2000-12-31-36.45%
1999-12-31-14.92%
1998-12-31--0.09%
1997-12-31-17.10%
1996-12-31-42.85%
1995-12-31-13.61%
1994-12-31-17.07%
1993-12-31--

Teva Pharmaceutical Industries generated $15.85B in revenue during NA 2023, up 6.17% compared to the previous quarter, and up 84.05% compared to the same period a year ago.

Teva Pharmaceutical Industries Revenue by Quarter

DateRevenueChange
2024-09-30-4.08%
2024-06-30-8.61%
2024-03-31--14.02%
2023-12-31-15.77%
2023-09-30--0.72%
2023-06-30-5.93%
2023-03-31--5.74%
2022-12-31-8.04%
2022-09-30--5.02%
2022-06-30-3.39%
2022-03-31--10.71%
2021-12-31-5.51%
2021-09-30--0.61%
2021-06-30--1.81%
2021-03-31--10.56%
2020-12-31-11.92%
2020-09-30-2.79%
2020-06-30--11.18%
2020-03-31--2.48%
2019-12-31-4.78%
2019-09-30--1.68%
2019-06-30-0.98%
2019-03-31--5.79%
2018-12-31-0.66%
2018-09-30--3.66%
2018-06-30--7.19%
2018-03-31--7.22%
2017-12-31--2.69%
2017-09-30--1.34%
2017-06-30-0.99%
2017-03-31--13.28%
2016-12-31-16.70%
2016-09-30-10.42%
2016-06-30-4.74%
2016-03-31--1.45%
2015-12-31-1.20%
2015-09-30--2.88%
2015-06-30--0.32%
2015-03-31--3.60%
2014-12-31-2.17%
2014-09-30-0.26%
2014-06-30-0.88%
2014-03-31--7.90%
2013-12-31-7.33%
2013-09-30-2.74%
2013-06-30-0.47%
2013-03-31--6.63%
2012-12-31-5.57%
2012-09-30--0.44%
2012-06-30--2.12%
2012-03-31--10.11%
2011-12-31-30.66%
2011-09-30-3.13%
2011-06-30-3.24%
2011-03-31--7.65%
2010-12-31-3.95%
2010-09-30-11.84%
2010-06-30-4.02%
2010-03-31--3.92%
2009-12-31-7.10%
2009-09-30-4.41%
2009-06-30-8.04%
2009-03-31-10.50%
2008-12-31-0.21%
2008-09-30-0.67%
2008-06-30-9.76%
2008-03-31--

Teva Pharmaceutical Industries generated $4.33B in revenue during Q3 2024, up 4.08% compared to the previous quarter, and up 111.71% compared to the same period a year ago.

Teva Pharmaceutical Industries Revenue Breakdown

Teva Pharmaceutical Industries Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Other Activities-----
International Markets-----

Teva Pharmaceutical Industries's latest annual revenue breakdown by segment (product or service), as of Dec 23: International Markets (67.89%), and Other Activities (32.11%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Product--------------------
Product and Service, Other--------------------
License--------------------
Distribution Service--------------------
Other Activities--------------------
International Markets--------------------
TREANDA and BENDEKA--------------------
Pro Air--------------------
Austedo--------------------
Anda--------------------
AJOVY--------------------
QVAR--------------------

Teva Pharmaceutical Industries's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (87.60%), Distribution Service (9.00%), Product and Service, Other (2.36%), and License (1.04%).

Teva Pharmaceutical Industries Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
North America-----
Europe-----

Teva Pharmaceutical Industries's latest annual revenue breakdown by geography, as of Dec 23: North America (62.68%), and Europe (37.32%).

Quarterly Revenue by Country

CountrySep 24Jun 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
UNITED STATES--------------------
Europe--------------------
North America--------------------

Teva Pharmaceutical Industries's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (63.75%), and Europe (36.25%).

Teva Pharmaceutical Industries Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
TAKTakeda Pharmaceutical Company--
TEVATeva Pharmaceutical Industries--
VTRSViatris--
HLNHaleon--
BHCBausch Health Companies--
ZTSZoetis--
ELANElanco Animal Health--
CTLTCatalent--
SNDLSNDL--
TLRYTilray Brands--
CGCCanopy Growth--
ACBAurora Cannabis--
HEXOHEXO--
LFCRLifecore Biomedical--
CRONCronos Group--
LSDILucy Scientific Discovery--
SHPHShuttle Pharmaceuticals--

TEVA Revenue FAQ

What is Teva Pharmaceutical Industries’s yearly revenue?

Teva Pharmaceutical Industries's yearly revenue for 2023 was $15.85B, representing an increase of 6.17% compared to 2022. The company's yearly revenue for 2022 was $14.92B, representing a decrease of -6.00% compared to 2021. TEVA's yearly revenue for 2021 was $15.88B, representing a decrease of -4.68% compared to 2020.

What is Teva Pharmaceutical Industries’s quarterly revenue?

Teva Pharmaceutical Industries's quarterly revenue for Q3 2024 was $4.33B, a 4.08% increase from the previous quarter (Q2 2024), and a 12.52% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $4.16B, a 8.61% increase from the previous quarter (Q1 2024), and a 7.32% increase year-over-year (Q2 2023). TEVA's quarterly revenue for Q1 2024 was $3.83B, a -14.02% decrease from the previous quarter (Q4 2023), and a 4.67% increase year-over-year (Q1 2023).

What is Teva Pharmaceutical Industries’s revenue growth rate?

Teva Pharmaceutical Industries's revenue growth rate for the last 3 years (2021-2023) was -0.20%, and for the last 5 years (2019-2023) was -6.16%.

What are Teva Pharmaceutical Industries’s revenue streams?

Teva Pharmaceutical Industries's revenue streams in c 23 are Other Activities, and International Markets. Other Activities generated $926M in revenue, accounting 32.11% of the company's total revenue, down -11.39% year-over-year. International Markets generated $1.96B in revenue, accounting 67.89% of the company's total revenue, up 2.89% year-over-year.

What is Teva Pharmaceutical Industries’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Teva Pharmaceutical Industries was International Markets. This segment made a revenue of $1.96B, representing 67.89% of the company's total revenue.